Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.39 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | MGMT | P16455 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL674285 | 1.00 | ALDH1A1 (0.46) | ALDH1A1ALOX15CYP1B1TSHRMAPK1 | |
| SCHEMBL12324194 | 0.94 | ALDH1A1 (0.45) | ALDH1A1ALOX15CYP1B1TSHRMAPK1 | |
| SCHEMBL674829 | 0.89 | ALDH1A1 (0.46) | ALDH1A1ALOX15CYP1B1TSHRMAPK1 | |
| SCHEMBL4785327 | 0.82 | ALOX15 (0.50) | ALDH1A1ALOX15CYP1B1TSHRMAPK1 | |
| SCHEMBL28534875 | 0.81 | CES2 (0.44) | ALDH1A1MAPK1CES2NPC1PTPN2 | |
| SCHEMBL676708 | 0.79 | ALOX15 (0.47) | ALDH1A1ALOX15CYP1B1TSHRMAPK1 | |
| SCHEMBL674176 | 0.77 | ALOX15 (0.50) | ALDH1A1ALOX15CYP1B1TSHRMAPK1 | |
| SCHEMBL16002382 | 0.77 | ALOX15 (0.62) | ALDH1A1ALOX15CYP1B1TSHRMAPK1 | |
| SCHEMBL1302136 | 0.77 | ALOX15 (0.62) | ALDH1A1ALOX15CYP1B1TSHRMAPK1 | |
| SCHEMBL678301 | 0.76 | ALDH1A1 (0.49) | ALDH1A1ALOX15CYP1B1TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239730-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2024-07-18 | — | — | US | disclosed |
| US-20240239730-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2024-07-18 | — | — | US | disclosed |
| US-20240239730-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2024-07-18 | — | — | US | disclosed |
| US-20230405125-A1 | TREATMENT OF RECURRENT GIOBLASTOMA WITH PERILLYL ALCOHOL | Neonc Technologies, Inc. | 2023-12-21 | — | — | US | disclosed |
| EP-4243794-A1 | TREATMENT OF RECURRENT GIOBLASTOMA WITH PERILLYL ALCOHOL | Neonc Technologies, Inc. (US) | 2023-09-20 | — | — | EP | disclosed |
| CN-116615197-A | Treatment of recurrent glioblastoma with perillyl alcohol | NeOnc技术股份有限公司 | 2023-08-18 | — | — | CN | disclosed |
| WO-2022104041-A1 | TREATMENT OF RECURRENT GIOBLASTOMA WITH PERILLYL ALCOHOL | Neonc Technologies, Inc. (US) | 2022-05-19 | — | — | WO | disclosed |
| EP-3769754-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | Neonc Technologies, Inc. (US) | 2021-01-27 | — | — | EP | disclosed |
| US-10899691-B2 | Pharmaceutical compositions comprising monoterpenes | Neonc Technologies, Inc. (US) | 2021-01-26 | — | — | US | disclosed |
| EP-2542082-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-perillyl alcohol | NEONC TECH INC (US) | 2020-05-06 | — | — | EP | disclosed |
| US-20130303807-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | UNIVERSITY OF SOUTHERN CALIFORNIA | 2013-11-14 | — | — | US | disclosed |
| US-20130303807-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | UNIVERSITY OF SOUTHERN CALIFORNIA | 2013-11-14 | — | — | US | disclosed |
| US-20130303807-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | UNIVERSITY OF SOUTHERN CALIFORNIA | 2013-11-14 | — | — | US | disclosed |
| US-8507734-B2 | Pharmaceutical compositions comprising monoterpenes | NEONC TECHNOLOGIES INC. (US) | 2013-08-13 | — | — | US | disclosed |
| US-8507734-B2 | Pharmaceutical compositions comprising monoterpenes | NEONC TECHNOLOGIES INC. (US) | 2013-08-13 | — | — | US | disclosed |
| US-8507734-B2 | Pharmaceutical compositions comprising monoterpenes | NEONC TECHNOLOGIES INC. (US) | 2013-08-13 | — | — | US | disclosed |
| EP-2542082-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | Neonc Technologies Inc. (US) | 2013-01-09 | — | — | EP | disclosed |
| US-20110280860-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | NEONC TECHNOLOGIES INC. | 2011-11-17 | — | — | US | disclosed |
| US-20110280860-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | NEONC TECHNOLOGIES INC. | 2011-11-17 | — | — | US | disclosed |
| WO-2011109635-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | NEONC TECHNOLOGIES INC. (US) | 2011-09-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239730-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | SQLE, DHPS, GGPS1 | ALDH1A1 793/4885ALOX15 35/4885CYP1B1 26/4885 |
| US-20110280860-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | SQLE, DHPS, GGPS1 | ALDH1A1 793/4885ALOX15 35/4885CYP1B1 26/4885 |
| US-10899691-B2 | Pharmaceutical compositions comprising monoterpenes | SQLE, DHPS, GGPS1 | ALDH1A1 793/4885ALOX15 35/4885CYP1B1 26/4885 |
| US-20230405125-A1 | TREATMENT OF RECURRENT GIOBLASTOMA WITH PERILLYL ALCOHOL | IDH3A, IDH1, IDH3B | ALDH1A1 162/4885ALOX15 1329/4885CYP1B1 2195/4885 |
| US-20130303807-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | SQLE, DHPS, GGPS1 | ALDH1A1 793/4885ALOX15 35/4885CYP1B1 26/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.